OneMedNet receives Nasdaq deficiency notice for MVLS below $35M; also flagged on equity and income; 180-day cure period.

OneMedNet Corp

Nasdaq notified OneMedNet on Oct 8, 2024 that its MVLS ($35M minimum) was below threshold for 30 consecutive business days, violating Rule 5550(b)(2).
Nasdaq also cited non-compliance with $2.5M minimum stockholders' equity (Rule 5550(b)(1)) and $500K net income (Rule 5550(b)(3)).
Company has 180 days, until April 7, 2025, to regain MVLS compliance: close at or above $35M for 10 consecutive business days.
Deficiency notice does not currently affect trading; company intends to monitor and evaluate options but cannot assure compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.